TSPO, an outer-mitochondrial-membrane protein widely overexpressed in GBM, enhances resistance to chemotherapy and radiotherapy by restraining the caspase-9/Apaf-1-dependent mitochondrial apoptosis pathway 41. The gene discussed is TSPO; the disease is glioblastoma.